1. Home
  2. OPLN vs CELC Comparison

OPLN vs CELC Comparison

Compare OPLN & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPENLANE Inc.

OPLN

OPENLANE Inc.

N/A

Current Price

$27.46

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Celcuity Inc.

CELC

Celcuity Inc.

HOLD

Current Price

$115.02

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPLN
CELC
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
OPLN
CELC
Price
$27.46
$115.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$32.00
$106.63
AVG Volume (30 Days)
1.0M
538.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.81
$7.58
52 Week High
$31.78
$120.32

Technical Indicators

Market Signals
Indicator
OPLN
CELC
Relative Strength Index (RSI) 41.45 56.96
Support Level $27.45 $97.75
Resistance Level $29.60 $114.54
Average True Range (ATR) 0.86 5.27
MACD 0.00 0.32
Stochastic Oscillator 50.76 67.83

Price Performance

Historical Comparison
OPLN
CELC

About OPLN OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: